- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05149144
Comutti - A Research Project Dedicated to Finding Smart Ways of Using Technology for a Better Tomorrow for Everyone, Everywhere. (COMUTTI)
According to World Health Organization, worldwide one in 160 children has an ASD. About around 25% to 30% of children are unable to use verbal language to communicate (non-verbal ASD) or are minimally verbal, i.e., use fewer than 10 words (mv-ASD). The ability to communicate is a crucial life skill, and difficulties with communication can have a range of negative consequences such as poorer quality of life and behavioural difficulties. Communication interventions generally aim to improve children's ability to communicate either through speech or by supplementing speech with other means (e.g., sign language, pictures, or AAC - Advanced Augmented Communication tools). Individuals with non- verbal ASD or mv-ASD often communicate with people through vocalizations that in some cases have a self-consistent phonetic association to concepts (e.g., "ba" to mean "bathroom") or are onomatopoeic expressions (e.g., "woof" to refer to a dog). In most cases vocalizations sound arbitrary; even if they vary in tone, pitch, and duration depending it is extremely difficult to interpret the intended message or the individual's emotional or physical state they would convey, creating a barrier between the persons with ASD and the rest of the world that originate stress and frustration. Only caregivers who have long term acquaintance with the subjects are able to decode such wordless sounds and assign them to unique meanings.
This project aims at defining algorithms, methods, and technologies to identify the communicative intent of vocal expressions generated by children with mv-ASD, and to create tools that help people who are not familiar with the subjects to understand these individuals during spontaneous conversations.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alessandro Crippa, Ph.D.
- Phone Number: +39 031877593
- Email: alessandro.crippa@lanostrafamiglia.it
Study Locations
-
-
Lecco
-
Bosisio Parini, Lecco, Italy, 23842
- Recruiting
- Scientific Institute, IRCCS Eugenio Medea
-
Contact:
- Mariaelena Colombo
- Phone Number: +39 031877357
- Email: mariaelena.colombo@lanostrafamiglia.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- having a clinical diagnosis of autism spectrum disorder according to DSM-5 criteria
- use fewer than 10 words
Exclusion Criteria:
- using any stimulant or non-stimulant medication affecting the central nervous system
- having an identified genetic disorder
- having vision or hearing problems
- suffering from chronic or acute medical illness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental: audiosignal dataset creation and machine learning analysis
Experimental: audiosignal dataset creation and processing; machine learning analysis, empirical evaluations
|
Clinical evaluation of participants by means of Autism Diagnostic Observation Schedule
The project tests and adapts the technology developed at MIT for vocalization collection and labeling, and contributes to data gathering among Italian subjects (and their quality validation) in order to create a multi-cultural dataset and to enable cross-cultural studies and analyses.
Next, the focus is placed on the analysis of harmonic features of the audio in the vocalizations of the dataset to identify recurring individual features and patterns corresponding to specific communications purposes or emotional states.
Supervised and unsupervised machine learning approaches are developed and different machine learning algorithms will be compared to identify the most accurate ones for the project goal.
Last, an exploratory evaluation of the vocalization-understanding machine learning model is conducted to test the usability and utility of the tool for vocalization interpretation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of audio signal samples and their associated labels
Time Frame: immediately after the intervention
|
Frequency (measured in number per hour) of audio signal samples (sounds and verbalizations) produced by each participant recorded during the hospital stays, in various contexts (i.e., during educational interventions and / or in moments of unstructured play) labeled as self-talk, delight, dysregulation, frustration, request, or social exchange. A small, wireless recorder (Sony TX800 Digital Voice Recorder TX Series) will be attached to the participant's clothing using strong magnets. Next, the adults (caregiver and / or operators) must associate the sounds produced by the child to an affective and / or to the probable meaning of the vocalization -labels- through the use of a web app. |
immediately after the intervention
|
Participant-specific harmonic features derived by the audio signal samples
Time Frame: immediately after the intervention
|
Temporal and spectral audio features -i.e., pitch-related features, formants features, energy-related features, timing features, articulation features- extracted from the samples and used next for supervised and unsupervised machine learning analysis. The collected audio signal samples will be segmented in the proximity of the temporal locations of labels. Next, it will be segmented and associated with temporally adjacent labels (affective states or probable meaning of vocalizations). Audio harmonic features (temporal/phonetic characteristics) will be then identified for each participant using supervised/unsupervised machine learning analysis of audio signal samples. Through this process, participant-specific patterns corresponding to specific communications purposes or emotional states will be identified. |
immediately after the intervention
|
Accuracy of machine learning prediction
Time Frame: immediately after the intervention
|
The classification accuracy of machine learning analysis, i.e., the number of correct predictions divided by the total number of predictions, which will be tested in a retained test set of recorded audio signal samples. This outcome measures will estimate the usability/utility of the developed tool for vocalization interpretion based on a machine learning analysis of the recorded audio signal samples. |
immediately after the intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alessandro Crippa, Ph.D., IRCCS Eugenio Medea
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 868
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on Clinical evaluation of participants by means of Autism Diagnostic Observation Schedule
-
Etablissement Public de Santé Barthélemy DurandNot yet recruitingNeurocognitive Disorders | Autism Spectrum Disorder | Language Development | Child LanguageFrance
-
IRCCS San RaffaeleRecruitingInfertility | Male InfertilityItaly
-
State University of New York - Upstate Medical...National Institute of Mental Health (NIMH); University of Missouri-Columbia; Baylor... and other collaboratorsCompletedAutism Spectrum Disorder | Developmental DelayUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Groupe Hospitalier Pitie-SalpetriereCompletedHealth, Subjective | Health Knowledge, Attitudes, Practice | Safety IssuesFrance
-
Centre Hospitalier Universitaire de NīmesUniversity Hospital, Montpellier; M2H laboratory, Montpellier University; IMT... and other collaboratorsCompletedStroke | Brain Hypoxia | Traumatic Brain Injury With Prolonged Loss of ConsciousnessFrance
-
Consorci Sanitari de l'Alt Penedès i GarrafNot yet recruitingAcute DiseaseSpain
-
Cancer and Leukemia Group BNational Cancer Institute (NCI)Unknown
-
Universidad Complutense de MadridCompleted
-
Fundación para la Investigación del Hospital Clínico...CompletedHeart Failure With Reduced Ejection FractionSpain